Noelani Hobbs, MD
Family Medicine · Waipahu, HINPI 1295174175
Payments from drug & device makers
Across 1,026 payments — averaging $22.86 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amgen$4K
- AbbVie$3K
- AstraZeneca$3K
- Novo Nordisk$2K
- Amarin Pharma, Inc.$2K
- GSK$1K
- plus $9K from 27 others
What the payments were for
- Speaking & faculty fees$8053%
- Travel & lodging$330%
- Food & beverage$22,56496%
- Education$510%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Amgen(2 entities) | 139 | $3,838 |
| AbbVie(2 entities) | 104 | $2,995 |
| AstraZeneca | 95 | $2,938 |
| Novo Nordisk | 104 | $1,514 |
| Amarin Pharma, Inc. | 54 | $1,512 |
| GSK | 115 | $1,407 |
| Insmed, Inc. | 58 | $1,278 |
| Boehringer Ingelheim | 50 | $1,180 |
| Lilly USA, LLC | 46 | $990 |
| Bayer | 28 | $918 |
| Sanofi-aventis U.S. LLC | 33 | $728 |
| Pfizer | 28 | $726 |
| Merck | 25 | $578 |
| Arbor Pharmaceuticals, Inc. | 41 | $502 |
| Johnson & Johnson | 21 | $432 |
| Novartis | 17 | $383 |
| Radius Health, Inc. | 17 | $209 |
| Kowa Pharmaceuticals America, Inc. | 17 | $208 |
| Galt Pharmaceuticals, LLC | 1 | $172 |
| Genentech USA, Inc. | 3 | $168 |
| Esperion Therapeutics, Inc. | 6 | $137 |
| Bioventus LLC | 1 | $131 |
| Ironwood Pharmaceuticals, Inc | 7 | $130 |
| Nestle Healthcare Nutrition Inc. | 4 | $83 |
| Aimmune Therapeutics, Inc. | 2 | $67 |
| Dexcom, Inc. | 2 | $62 |
| E.r. Squibb & Sons, L.L.C. | 2 | $50 |
| Catalyst Pharmaceuticals, Inc. | 1 | $30 |
| Agile Therapeutics, Inc. | 1 | $25 |
| Biohaven Pharmaceuticals, Inc. | 1 | $22 |
| Astellas Pharma US Inc | 1 | $17 |
| Philips North America LLC | 1 | $13 |
| Dermira, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$23,453 in reported general payments places this provider in the 95th percentile of 376 family medicine providers in Hawaii.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| JanuviaSitagliptin Phosphate | 106 | $122,840 |
| JardianceEmpagliflozin | 81 | $104,061 |
| TradjentaLinagliptin | 60 | $69,478 |
| VascepaIcosapent Ethyl | 85 | $67,315 |
| FarxigaDapagliflozin Propanediol | 38 | $63,664 |
| ProliaDenosumab | 32 | $56,354 |
| CreonLipase/Protease/Amylase | 13 | $49,235 |
| RybelsusSemaglutide | 35 | $46,353 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 25 | $33,402 |
| XareltoRivaroxaban | 37 | $29,518 |
| EliquisApixaban | 20 | $28,449 |
| LinzessLinaclotide | 17 | $25,714 |
| OzempicSemaglutide | 16 | $23,011 |
| Janumet XrSitagliptin Phos/Metformin Hcl | 18 | $20,448 |
| Atorvastatin Calcium | 1,045 | $19,778 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Boehringer IngelheimJardiance, Tradjenta | $1,180 | $173,539141 claims |
| MerckJanuvia, Janumet Xr, Janumet | $578 | $158,506147 claims |
| AstraZenecaFarxiga, Symbicort, Breztri Aerosphere | $2,938 | $91,68588 claims |
| AbbVieCreon, Linzess, Synthroid | $2,995 | $79,89470 claims |
| Novo NordiskRybelsus, Ozempic | $1,514 | $69,36451 claims |
| AmgenProlia | $3,838 | $56,35432 claims |
| GSKTrelegy Ellipta, Breo Ellipta | $1,407 | $42,05838 claims |
| Johnson & JohnsonXarelto | $432 | $29,51837 claims |
| PfizerEliquis | $726 | $28,44920 claims |
| Kowa Pharmaceuticals America, Inc.Livalo | $208 | $12,54413 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 376 family medicine providers in Hawaii.
Other family medicine in Waipahu
- Edward AlqueroWaipahu$24K
- Judith HernaezWaipahu$7K
- Gloria Eden DomingoWaipahu$3K
- Hugh MooreKoloa$237K
- Brian StolleyKihei$126K
- Vicente RamoHonolulu$34K
- Johnnie YatesHonolulu$25K
- Rainier Dennis BautistaLihue$23K
- Choon YeoHonolulu$20K
- Buddy FesterlingHilo$20K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.